论文部分内容阅读
脂质体在20世纪60年代被英国Bangham等发现,70 年代Gregoriadis等首次提出应用脂质体作为β-半乳糖苷酶载体治疗糖原积累疾病。此后,人们开始应用脂质体作为载体进行各方面的研究和疾病的治疗,如药物载体、基因介导以及治疗感染性疾病、心血管疾病和皮肤疾病等。脂质体在治疗胰腺炎方面的研究资料尚少,但为胰腺炎的治疗指
Liposomes in the 20th century, the United Kingdom by Bangham and other found that the 70’s Gregoriadis first proposed the use of liposomes as β-galactosidase vector treatment of glycogen accumulation disease. Since then, people began to use liposomes as carriers for various aspects of research and treatment of diseases, such as drug carriers, gene mediation and treatment of infectious diseases, cardiovascular diseases and skin diseases. Liposomes in the treatment of pancreatitis is still little research information, but for the treatment of pancreatitis refers to